Breakthrough invasive fungal infections (bIFI) cause significant morbidity and mortality. Their diagnosis can be challenging due to reduced sensitivity to conventional culture techniques. serologic tests. and PCR-based assays in patients undergoing antifungal therapy. https://www.chiggate.com/earthbath-facial-wipes-25ct-fashion/